20-2817002-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001167670.3(TMEM239):āc.448T>Gā(p.Leu150Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000144 in 1,385,584 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001167670.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM239 | NM_001167670.3 | c.448T>G | p.Leu150Val | missense_variant | 2/2 | ENST00000380585.2 | NP_001161142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM239 | ENST00000380585.2 | c.448T>G | p.Leu150Val | missense_variant | 2/2 | 1 | NM_001167670.3 | ENSP00000369959 | P1 | |
TMEM239 | ENST00000361033.1 | c.577T>G | p.Leu193Val | missense_variant | 2/2 | 2 | ENSP00000354312 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000689 AC: 1AN: 145142Hom.: 0 AF XY: 0.0000129 AC XY: 1AN XY: 77234
GnomAD4 exome AF: 0.00000144 AC: 2AN: 1385584Hom.: 0 Cov.: 36 AF XY: 0.00 AC XY: 0AN XY: 683700
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.448T>G (p.L150V) alteration is located in exon 2 (coding exon 1) of the TMEM239 gene. This alteration results from a T to G substitution at nucleotide position 448, causing the leucine (L) at amino acid position 150 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at